Customer Service:
Mon - Fri: 8:30 am - 6 pm EST

 Historical

CLSI I/LA25-A2

Maternal Serum Screening; Approved Standard - Second Edition (Reaffirmed September 2018) (Archived)

This document addresses the steps required to provide reliable screening and reporting using examples of serum markers currently in common use (AFP, hCG, uE3, inhibin A, PAPP-A). Emphasized is first-trimester screening, in which serum markers used are PAPP-A and hCG, and the main ultrasound marker is nuchal translucency. Outcome evaluation, information management, and calculation of risk are also emphasized. (Reaffirmed September 2018)


Content Provider
Clinical And Laboratory Standards Institute [clsi]


Document History
Revises:
  • ILA25-A
Included in Packages
This standard is not included in any packages.
Amendments & Corrections
We have no amendments or corrections for this standard.
ANSI Logo

As the voice of the U.S. standards and conformity assessment system, the American National Standards Institute (ANSI) empowers its members and constituents to strengthen the U.S. marketplace position in the global economy while helping to assure the safety and health of consumers and the protection of the environment.

CUSTOMER SERVICE
NEW YORK OFFICE
ANSI HEADQUARTERS